Valentia Technologies New Zealand Limited plans to create 35 new high-value technology jobs in Hamilton. The expansion will make the city a key centre for the company’s next generation of AI and digital healthcare solutions for the Asia-Pacific region.
It follows the successful deployment of Valentia’s healthcare technology across oncology, patient engagement, primary care, telehealth and emergency medical services. That work includes the Maha/Raurau oncology system and the OctansCare patient engagement platform.
The new roles will form part of Valentia’s Asia-Pacific Centre of Development in Hamilton. From Hamilton, the team will build and implement secure, cloud-based AI solutions for healthcare organisations across New Zealand and the wider Asia-Pacific.
Investing in New Zealand
Valentia has been developing healthcare technology in New Zealand for over 10 years. The new positions will span AI, software engineering, cloud technologies, healthcare informatics, product development and quality assurance. They reinforce the company’s commitment to supporting advanced healthcare technology development in New Zealand.
Expanding AI Across Healthcare and Well-being
Healthcare organisations will remain a primary focus. Building on OctansCare, Valentia will also develop AI-powered tools for personalised health management, wellbeing, nutrition and fitness, connected to appropriate healthcare services. Valentia also plans to partner with healthcare, technology and specialist organisations to further develop and deploy its VIVASTA connected continuity-of-care platform.
Dr. Ahmad Javad, Chief Executive of Valentia Technologies, said:
“New Zealand has been an important part of our technology journey for over a decade. We have built products for this market, employed highly skilled people here and worked closely with the health sector, from primary and community care, cancer care through Maha/Raurau to patient engagement through OctansCare.
“Creating 35 jobs in Hamilton reflects our confidence in New Zealand’s technology capability. We want to develop the next generation of AI-enabled healthcare solutions here and take that innovation into the wider Asia-Pacific. Our objective is not simply to develop individual AI tools, but to create an ecosystem that supports continuity of care, connecting healthcare organisations, clinicians, consumers and complementary services around the individual.”
New Zealand Innovation for the Asia-Pacific
The Hamilton centre positions New Zealand not simply as a market for Valentia’s products, but as a base for creating and exporting digital health innovation across the region.
